Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

  • The COVID Moonshot consortium
  • , Alpha A. Lee
  • , Hagit Achdout
  • , Anthony Aimon
  • , Dominic S. Alonzi
  • , Robert Arbon
  • , Jasmin C. Aschenbrenner
  • , Blake H. Balcomb
  • , Elad Bar-David
  • , Haim Barr
  • , Amir Ben-Shmuel
  • , James Bennett
  • , Vitaliy A. Bilenko
  • , Melissa L. Boby
  • , Bruce Borden
  • , Pascale Boulet
  • , Gregory R. Bowman
  • , Lennart Brewitz
  • , Juliane Brun
  • , Sarma Bvnbs
    • Mark Calmiano, Anna Carbery, Daniel W. Carney, Emma Cattermole, Edcon Chang, Eugene Chernyshenko, John D. Chodera, Austin Clyde, Joseph E. Coffland, Galit Cohen, Jason C. Cole, Alessandro Contini, Lisa Cox, Tristan Ian Croll, Milan Cvitkovic, Steven De Jonghe, Alex Dias, Kim Donckers, David L. Dotson, Alice Douangamath, Shirly Duberstein, Tim Dudgeon, Louise E. Dunnett, Peter Eastman, Noam Erez, Charles J. Eyermann, Michael Fairhead, Gwen Fate, Daren Fearon, Oleg Fedorov, Vincent Voelz

Research output: Contribution to journal › Article › peer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Chemistry

Chemical Engineering